Literature DB >> 34495390

Cone Beam CT Guidance Improves Transbronchial Lung Cryobiopsy Safety.

Bryan S Benn1, Arthur Oliver Romero2,3, Hasnain Bawaadam2, Nathaniel Ivanick2,4, Mendy Lum5, Ganesh Krishna2,6.   

Abstract

INTRODUCTION: Determining the cause of diffuse parenchymal lung disease (DPLD) is challenging. While surgical lung biopsy has been the standard approach, transbronchial lung cryobiopsy (TBLC) represents a minimally invasive alternative with an acceptable safety profile and reasonable accuracy. In this study, we prospectively assessed whether the use of cone beam CT (CBCT) coupled with a novel bronchoscope holder and prophylactic administration of vasoconstricting medications decreases potential complications and improves diagnostic accuracy when performing TBLC.
METHODS: 33 patients presenting for evaluation of newly diagnosed DPLD were enrolled. Demographic data, pulmonary function values, chest imaging pattern, procedural information, and diagnosis were recorded.
RESULTS: Mean patient age was 67, with the majority Caucasian (n = 26, 79%) and male (n = 20, 61%). Mean pulmonary function values revealed restrictive lung disease (76 ± 14% predicted) and diffusing capacity impairment (52 ± 16%). A non-usual interstitial pneumonia imaging pattern was commonly seen (n = 20, 61%). CBCT guided TBLC was performed in one lobe (n = 29, 88%) or two lobes (n = 4, 12%) with mean probe-to-pleura distance of 4.2 ± 1.3 mm. No peri or post procedural complications occurred. 32 patients (97%) received a histological diagnosis with a final multidisciplinary conference diagnosis possible for 32 (97%).
CONCLUSION: CBCT guided TBLC coupled with a novel articulating scope holder and prophylactic phenylephrine administration has the potential to increase safety and diagnostic yield for patients with newly identified DPLD. Future studies comparing different aspects of this approach in isolation and with other modalities have the potential to refine this procedure to improve patient care.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cone beam CT; Diffuse parenchymal lung disease; Interstitial lung disease; Transbronchial lung cryobiopsy

Mesh:

Year:  2021        PMID: 34495390     DOI: 10.1007/s00408-021-00473-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  3 in total

1.  Topical application of epinephrine during bronchoscopy in barbiturate-halothane-anaesthesia and its influence on cardiac action.

Authors:  W Mall; H Abel
Journal:  Bronchopneumologie       Date:  1978 Jul-Aug

2.  Transbronchial Lung Cryobiopsy and Video-assisted Thoracoscopic Lung Biopsy in the Diagnosis of Diffuse Parenchymal Lung Disease. A Meta-analysis of Diagnostic Test Accuracy.

Authors:  Imran H Iftikhar; Lana Alghothani; Alejandro Sardi; David Berkowitz; Ali I Musani
Journal:  Ann Am Thorac Soc       Date:  2017-07

Review 3.  Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management.

Authors:  Maurizio Bernasconi; Coenraad F N Koegelenberg; Angela Koutsokera; Adam Ogna; Alessio Casutt; Laurent Nicod; Alban Lovis
Journal:  ERJ Open Res       Date:  2017-06-21
  3 in total
  4 in total

1.  Navigational Bronchoscopy with Cryobiopsy for Diagnosis of ILD.

Authors:  Fernando Figueroa Rodriguez; Asfar Ghauri; Tony Abdo; Salim Daouk; Shideler Barbara; Houssein A Youness
Journal:  Case Rep Pulmonol       Date:  2022-09-17

2.  Evaluation of large airway specimens obtained by transbronchial lung cryobiopsy in diffuse parenchymal lung diseases.

Authors:  S Sato; H Yamakawa; T Takemura; T Nakamura; T Nishizawa; T Oba; R Kawabe; K Akasaka; M Amano; H Matsushima
Journal:  BMC Pulm Med       Date:  2022-10-18       Impact factor: 3.320

3.  LUNG Year in Review: 2021.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2022-01-18       Impact factor: 3.777

4.  Transbronchial Lung Cryobiopsy is Safe and Effective for Diagnosing Acutely Ill Hospitalized Patients with New Diffuse Parenchymal Lung Disease.

Authors:  Carson Castellani; Henry Castellani; Bryan S Benn
Journal:  Lung       Date:  2022-02-01       Impact factor: 3.777

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.